ClearPoint Neuro Inc (CLPT) Options

CLPT under $10

Putting their funding to good use!

50% haircut last 6 months. Glad I didn't buy when you were hyping this. Looks like you are gone too.

Plenty of talk of her on the NWBO board. I'm long on NWBO.

Doesn't anybody ever talk about Dr. Linda Liau?

I bought in. Very exciting company

Oh wow great dip time to scoop some shares on sale

Nice news clear point neuro doing big things saving our lives go $CLPT https://www.globenewswire.com/news-release/2021/01/26/2164680/0/en/ClearPoint-Neuro-Inc-Announces-Expansion-of-Pre-Clinical-and-Translational-Development-Team-to-Support-Gene-and-Stem-Cell-Therapy-Partners.html

This stock has been great runner daily

Everyone missing out on this great stock of the year

Good after noon CLPT

Going be great in am

Yall missed this gem

Wow from 7 to 23 if u missed me calling out CLPT where were u

Good morning clear point looks like shell be going 30 today by end of week

All new highs here anyone missing this ?? losing a lot of free cash

$CLPT very Nice! I have too many plays!!! Very Nice!

$CLPT
Keep going up

Yall missing out on all this love

I like this gem keeps going up like stair case this will be at $50 easy

ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms

https://www.globenewswire.com/news-release/2020/12/29/2151415/0/en/ClearPoint-Neuro-Inc-Announces-Funding-of-Additional-7-5M-of-Existing-Convertible-Note-on-Improved-Terms.html

Ive been in since July its been a great ride for me

Nice Find

CLPT one to watch...

Outstanding Shares 16,869,528 11/10/2020

Brain surgery

The Restore-1 trial DSMB did not advise Neurocrine's team to pause or halt the trial back in November, Roberts said. However, it did recommend that the company discontinue its use of the neurosurgical procedure used in the trial at the time, she said. That was presumably a reference to the brain surgery procedure by which NBIb-1817 and another Voyager asset, VY-HTT-01, are designed to be delivered to targeted areas and cells in the brain.

In a previous phase I trial, conducted by the University of California, San Francisco, three patients experienced hemorrhages caused by the surgical procedure for administering VY-AADC, Voyager reported in its most recent quarterly report, on Nov. 9.

In response, in Restore-1, investigators began using Clearpoint Neuro Inc.'s Clearpoint System "to provide accurate placement of the cannula in the putamen and allow for real-time, intra-operative MRI to assist the physician in visualizing the delivery of VY-AADC (NBIb-1817) to the putamen and to avoid specific blood vessels during the duration of the surgical procedure, with the goal of reducing the risk of hemorrhages," Voyager said.

In the same quarterly filing, Voyager said that it might begin using V-TAG, a real-time, intra-operative, MRI-compatible device that it developed with Clearpoint for the procedures.

Even with those changes, the Restore-1 study had been on pause since earlier in the year due to what Roberts called a "major amendment to the study over the course of the summer," one that appears to have included a major streamlining of the trial's primary and secondary outcome measures. Furthermore, screening for the study had been paused as well, particularly in light of the need for trial participants to travel, sometimes across state lines for study-relating brain scans.

Neurocrine's efforts to resolve those issues weren't clear on Wednesday. But Cowen analyst Phil Nadeau remained cautiously optimistic. "The risk to NBIb-1817's further development, as well as the duration of the delay, can't be estimated without understanding the specific issues that the DSMB has identified," he said.

https://www.bioworld.com/articles/501751-fda-puts-parkinsons-trial-on-hold-amid-imaging-abnormalities

Wow im glad I know about this gem steadily going up lets have another great say $CLPT

This stock will be at 50 dollars one day soon don't get left out this gem

Don't sleep on this ticker is the way of future surgery

Watching the dips today